Redx Pharma Plc (LON:REDX)

Redx Pharma Plc (LON:REDX)


Share Price
5.35 p
Change
0 (0.00 %)
Market Cap
£6.77 m
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc

www.redxpharma.com

Overview

Figures in £(m) unless stated
Sales 0.129
EBITDA -9.981
Operating Profit -9.199
Pre-tax Profit -10.146
Net Profit -8.845
Capex -0.132
Operating Cash Flow -17.177
Net Working Capital 5.755
Key Ratios
EBITDA Margin -7737.209
Operating Profit Margin -71.310 -%
Net Profit Margin -68.566 -%
Capex/Sales (%) 1.023
NWC/Sales (%) -6856.5891472868
Asset Turnover 0.007
Days Inventory 0.000  days
Days Receivable 0.000  days
Days Payable 0.000  days
Performance (Last 3 Years)
Sales CAGR 0.000
EBITDA CAGR n/a
Operating Profit CAGR -
Profit CAGR -
Return on Equity(%) -88.049
Return on Assets(%) -46.543
Return on Invested Capital (ROIC)(%) -88.249
ROIC - WACC n/a
Valuation
Market Cap -
Price to Earnings 0.000
Price to Book Value 1.976
Price to Tangible Book -
Equity to FCF Yield -43.36
Enterprise Value -
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield -
Payout Ratio 0
Per Share Data (in GBp unless stated)
Earnings per share -0.070000
Operating Cashflow per share -0.13584249400904
Free Cashflow per share -0.062500
Dividend per share -
NAV per share -
Cash per share -0.062000
Solvency
Intangibles Incl. Excl.
Net debt to Equity % -112.26578764747 -121.15708668789
Cash to Equity % 112.26578764747 -42299887.734212
Gross debt to Equity % 0 0
Gross Debt < 1 Year to Equity - -
Net debt to Assets % 0 0
Net Debt/EBITDA 64.833183047791 -0
Net Interest Cover -10145.000000 n/a
Op Cashflow Interest Cover -17177 n/a
Current Ratio 2.456962 n/a
Quick Ratio 1.845316 n/a
Cash Ratio - n/a (Intangibles collected as non-current)
Dividend Cover - n/a
Key Dates
Latest Dividend Pay date n/a
Latest Ex-Dividend date n/a
Last Annual Results 2018-12-28
Last Interim Results 2018-12-28

Profit/Loss

Figures in £(m) unless stated30/09/1830/09/1730/09/1630/09/1530/09/1430/09/1330/09/12
Sales 0.12930.474-----
Cost of Goods Sold -------
Gross Profit -------
Operating Expenses 9.32817.09114.3929.4314.0143.3282.312
EBITDA -9.9812.341-14.799-8.341-3.771-3.102-2.308
Depreciation & Amortisation -------
EBIT (Operating Profit) -9.19913.383-14.392-9.431-4.014-3.328-2.312
Interest Expense/Income -0.0230.3300.2790.286---
Profit Before Tax -10.1461.646-15.407-8.825-4.263-3.581-2.426
Taxes on Income -1.3010.1180.114-0.650-0.910-0.389-0.323
Net Profit -8.8451.528-15.521-8.175-3.353-3.192-2.103
Net Margin -68.5660.050-----
Net profit/loss per share
Basic EPS -0.0700.014-0.198-0.141-0.052-0.049-0.032
Diluted EPS -0.0700.014-0.198-0.141-0.052-0.049-0.032

Balance sheet

 
Figures in £(m) unless stated 30/09/1830/09/1730/09/1630/09/1530/09/1430/09/1330/09/12
ASSETS        
Tangible Assets -------
Intangible Assets 0.4230.4300.3090.3090.3090.3090.309
Investments -------
Total Fixed Assets 0.6140.6521.4471.4120.6220.6370.605
Stocks -------
Debtors ---0.0211.8580.0050.014
Cash & Equivalents -------
Total Current Assets 9.70527.0377.94812.3446.4374.9991.254
Other Assets n/a        
Total Assets 10.31927.6899.39513.7567.0595.6361.859
LIABILITIES        
Interest bearing debt < 1 year 0.0002.0000.0002.0002.0000.000
Other Trade Creditors < 1 year -------
Total Creditors within 1 year 3.95013.3627.6754.0565.0774.8601.222
Interest bearing debt > 1 year --0.0002.0000.0000.0001.700
Other Trade Creditors > 1 year -------
Total Creditors > 1 year 0.0000.0000.0000.0000.0000.0000.000
Other Liabilities  n/a        
Total Liabilities 4.55513.3627.6756.0565.2394.8602.922
Net Assets(NET Tangible Assets exist) 5.34113.8971.4117.3911.5110.467-1.372
EQUITY        
Called up share capital 1.2651.2650.9360.6500.0070.0060.004
Share Premium 33.26433.26422.52713.51712.3137.9313.040
Profit / loss -29.927-21.082-22.610-7.089-10.652-7.299-4.107
Other Equity 1.1620.8800.8670.6220.1520.1380.000
Shareholders Funds 5.76414.3271.7207.7001.8200.776-1.063
Preference Stock -------
Total Capital Employed 5.76414.3271.7207.7001.8200.776-1.063

Cash flow

Figures in £(m) unless stated 30/09/1830/09/1730/09/1630/09/1530/09/1430/09/1330/09/12
EBITDA -8.8451.528-15.521-8.175-4.263-3.581-2.426
Change in Working Capital -8.3917.6861.1482.0301.181-0.937-0.677
Cash Taxes Paid -------
Cash Interest Paid/Received -------
Other (incl. non-cash items) 0.0230.0020.0360.019---
Net Cash from Operating Activities -17.17714.098-12.507-6.538-2.465-3.947-2.910
Capital Expenditure -0.132-0.154-0.444-0.362-0.054-0.277-0.309
Acquisitions/Disposals -------
Other Investing Activities -------
Net Cashflow from Investing Activities -0.109-0.030-0.442-0.362-0.054-0.277-0.309
Dividends -------
Increase/Decrease in Debt 0.000-1.975-0.025-0.0000.3001.700
Increase/Decrease in Equity 0.00012.36410.00013.4474.3834.8931.062
Other Financing Activities -0.049-6.409-0.704-0.0000.0000.000
Cash from Financing -0.0493.9809.27113.4444.3835.1932.762
Net increase in cash -17.33518.048-3.6786.5441.8640.969-0.457

Directors dealings

Date Director Trans Amount Type Price(p) Value (£) Holding %
- Dr. James Robert Mead - - Incentives - - 1200000.00
- Dominic Nicholas Jackson - - Incentives - - 500000.00
- Mr. Iain Gladstone Ross - - Ords 1.00p - - 600000.00 0.4743911
- Peter Eric Presland LLB,ACA,FInstD - - Ords 1.00p - - 120000.00 0.0948782
- Dr. Bernhard Jurgen Kirschbaum - - Ords 1.00p - - 50000.00 0.0395326
- Mr. Iain Gladstone Ross - - Incentives - - 3600000.00
- Ms. Lisa Mary Whewell Anson - - Incentives - - 3600000.00
2018-04-25 Mr. Iain Gladstone Ross P 150000.00 ORD 1P 11 16500 600000.00 0.4743911
- Mr. Norman Molyneux - - Incentives - - 250425.00
- Dr. Neil David Murray - - Incentives - - 75000.00
2017-12-22 Mr. Iain Gladstone Ross P 102000.00 ORD 1P 20.75 21165 450000.00 0.3557933
2017-12-22 Peter Eric Presland LLB,ACA,FInstD P 120000.00 ORD 1P 22 26400 120000.00 0.0948782
2017-12-22 Mr. Peter McPartland P 120000.00 ORD 1P 22 26400 200782.00 0.1587487
2017-12-27 Dr. Bernhard Jurgen Kirschbaum P 50000.00 ORD 1P 21 10500 50000.00 0.0395326
- Dominic Nicholas Jackson - - Incentives - - 500000.00
2017-11-14 Mr. Iain Gladstone Ross P 348000.00 ORD 1P 18.036 62765 348000.00 0.2751469
- Mr. Norman Molyneux - - ORD 1P - - 283436.00 0.2240992
- Dr. Neil David Murray - - ORD 1P - - 1293671.00 1.0228434
- Dr. Frank Murdoch Armstrong - - ORD 1P - - 46586.00 0.0368333
- Mr. Peter McPartland - - ORD 1P - - 80782.00 0.0638704
- Dr. Frank Murdoch Armstrong - - ORD 1P - - 46586.00 0.0368333
- Mr. Norman Molyneux - - ORD 1P - - 283436.00 0.2240992
- Dr. Neil David Murray - - ORD 1P - - 1293671.00 1.0228434
- Dr. Peter Jackson - - ORD 1P - - 3345428.00 2.6450689
- Dr. Peter Jackson - - ORD 1P - - 3345428.00 2.6450689
- Mr. Peter McPartland - - ORD 1P - - 80782.00 0.0638704
- Dr. Frank Murdoch Armstrong - - Incentives - - 473250.00
- Mr. Norman Molyneux - - Incentives - - 250425.00
- Dr. Neil David Murray - - Incentives - - 75000.00
- Dr. Peter Jackson - - Incentives - - 601275.00
- Mr. Philip John Tottey - - ORD 1P - - 35294.00 0.0279053
- Dr. Derek Lindsay - - ORD 1P - - 2002425.00 1.5832211
2016-04-04 Mr. Philip John Tottey E 35294.00 ORD 1P 42.5 15000 35294.00 0.0377264
- Dr. Neil David Murray - - ORD 1P - - 1265084.00 1.0002410
- Dr. Derek Lindsay - - ORD 1P - - 2002425.00 2.1404260
- Mr. Peter McPartland - - ORD 1P - - 77925.00 0.0616115

Dividends

Temporarily not available. Please try again later.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use